Christian Brun-Buisson, MD is professor of medicine and Intensive Care at University Paris-Est Créteil, and former director of the Medical Intensive Care Unit and of the Infection control unit at Henri Mondor Hospital. His areas of expertise include sepsis and severe infections, prevention and control of health-care associated infections and epidemiology and control of antimicrobial resistance. He has chaired the Infection Control Committee of the Paris public hospitals consortium (AP-HP, 1999-2011) and chairs (2005 – 2017) the Advisory Board for the French national programme for Prevention and Control of Health-Care Associated Infections at the MoH. Prof. Brun-Buisson has served on the editorial board of several medical journals, including JAMA, Am J Resp Crit Care Med, Intensive Care Med, and Infect Control Hosp Epidemiology. He is currently ministerial delegate for antimicrobial resistance at the French ministry of Health and Social Affairs.
Lower RESpiratory infections and sePSIs: Impact of COvid19 – REPSICO
Scientific Partners Muriel Fartoukh, Sorbonne University Partners DATAD of the Direction de la Stratégie, des Études et des Statistiques (DSES), Caisse Nationale de l’Assurance Maladie (Cnam) Fundings This project is funded by the Direction […]
INDUCE: INciDence and conseqUenCes of sEpsis in France
As recently acknowledged by the WHO, sepsis is the number one killer from infectious diseases, mostly bacterial infections, and as such has emerged as a major public health priority. Global estimates ascribe to sepsis […]
BactHub: Antibiotic exposure and antibiotic-resistant bacteremia in the community
Antibiotic resistance rates are increasing worldwide, especially for Gram-negative bacteria, potentially responsible for difficult-to-treat infections and therapeutic failures. While the high prevalence of resistance in hospitals is a long-lived concern, resistance is now spreading […]
MIBAC: Antibiotic use in the community
Since 2002 a centralized storage of therapeutic or preventive medications of bacterial infections in the community (MIBAC) has been initiated. Reimbursements for all systemic antibiotics (class J01 of the Anatomical Therapeutic classification), as well […]
PHIBRA: Bacterial resistance to antibiotics
Bacterial resistance to antibiotics has become a major public health issue. A recent report, delivered to the Minister of Health in September 2015, pointed out 158,000 cases of infections by antibiotic-resistant bacteria annually in […]
2023Care pathways of sepsis survivors: sequelae, mortality and use of healthcare services in France, 2015-2018., Crit Care 2023 Nov; 27(1): 438.
2022Antimicrobial Resistance and Mortality in Hospitalized Patients with Bacteremia in the Greater Paris Area from 2016 to 2019., Clin Epidemiol 2022 ; 14(): 1547-1560.
2021Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS), BMC Infect Dis 2021 Jun; 21(1): 571.
2021Outpatient antibiotic use attributable to viral acute lower respiratory tract infections during the cold season in France, 2010-2017, Int J Antimicrob Agents 2021 Jun; 57(6): 106339.
2021Costs and Outcomes of 1-year post-discharge care trajectories of patients admitted with infection due to antibiotic-resistant bacteria, J Infect 2021 03; 82(3): 339-345.
2019A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study, Appl Health Econ Health Policy 2019 Jun;17(3):381-389.
2019Hospitalisations with infections related to antimicrobial-resistant bacteria from the French nationwide hospital discharge database, 2016, Epidemiol. Infect. 2019 Jan;147:e144.
2017Comparing antibiotic consumption between two European countries: are packages an adequate surrogate for prescriptions?, Euro Surveill. 2017 Nov;22(46).